Noab Banoub, a third year medical student, describes his journey into medicine and his view of ophthalmology's future.
News|Articles|October 17, 2026
Varicose veins linked to central serous chorioretinopathy in large cohort study
Author(s)Lynda Charters
A higher risk of central serous chorioretinopathy and serous pigment epithelial detachment are associated with varicose veins.
Advertisement
Advertisement
A study in the British Journal of Ophthalmology1 reported that patients with varicose veins had a significantly higher risk of c
Related to this article
Eclipse Life Sciences reports that its biodegradable 6-month fluocinolone acetonide implant met its primary safety end point and beat the dexamethasone implant on visual and anatomic measures at 24 weeks.
Uveitis is uncommon, but it causes a disproportionate share of visual morbidity.
FDA accepts vamikibart BLA for UME as data show sustained gains at 1 year; decision July 2027.
Anti-VEGF for ROP is not associated with systemic and neurodevelopmental outcomes.
A cataract expert discussed if postoperative topical antibiotics add protection after intracameral prophylaxis.
Ryzumvi gained a presbyopia indication in adults based on the phase 3 VEGA-2 and VEGA-3 trials, adding a pharmacologic option for optometrists managing near vision loss.
Enspryng is the first subcutaneous, at-home treatment option for TED and the first interleukin (IL)-6 receptor inhibitor approved in the indication.
Advertisement
Advertisement